2024 Annual Conference On-Demand (Complete Conference Bundle)

Get It!

Welcome to the Annual Conference 2024 On-Demand Conference Sessions!
The sessions in this bundle were presented live in Tampa, FL from April 3-7, 2024.

Complete Conference Bundle Contents

  1. (BC1) Diving into DEI: Increasing Inclusivity and Fostering Diversity in Clinical Trials – 1.25 BCOP & 1.25 ACPE CE
  2. (101) Updates in Hematology – 1.25 ACPE CE
  3. (102) Platform Research Presentations – 1.0 ACPE CE
  4. (103) Updates in Hodgkin Lymphoma and the Role of the Pharmacist in Management of Toxicities – 1.0 ACPE CE
  5. (BC2) CAR T-Cell Breakthroughs in Lymphoma and Myeloma: Balancing Efficacy and Safety – 1.25 BCOP & 1.25 ACPE CE
  6. (BC3) The Great Financial Debate: Cost vs Margin for Cancer Care Drugs – 1.25 BCOP & 1.25 ACPE CE
  7. (BC4) Nuances in Neuro-Oncology: Glioma Treatment Advances and New Diagnostic (BCOP 101) – 1.0 BCOP & 1.0 ACPE CE
  8. (201) Moving Beyond One Size Fits All for Solid Tumors: Updates in Biomarker Driven Therapies – 1.25 ACPE CE
  9. (202) Breakout- Rare Malignancies: To Transplant or Not to Transplant: Current Treatment Approaches for Mantle Cell/Baby Steps: Updates in the Treatment of Infant Leukemia – 1.0 ACPE CE
  10. (203) Breakout- Updates in Medical Oncology: Advances in Targeted Therapies for Gastrointestinal Malignancies/Targeting HER2 Alterations in Patients With Non-Breast/Non-Gastric Cancers – 1.0 ACPE CE
  11. (204) Breakout-Practice Management: Show Me the Money: Optimizing the Electronic Medical Record (EMR) to Improve Biosimilar Utilization and Pharmacy Reimbursement/Cannabinoids and the Oncology Patient: Pearls for Pharmacists – 1.0 ACPE CE
  12. (205) Debating the Incorporation of Novel Therapies in Front-Line Acute Lymphoblastic Leukemia Treatment – 1.25 ACPE CE  
  13. (206) New Practitioner’s Guide to Navigating Your Career – 1.0 ACPE CE
  14. (207) REACHing for ROCKstars - Updates in Chronic Graft Versus Host Disease - 1.0 ACPE CE
  15. (BC5) Pharmacology and Clinical Application of Complement Inhibitors – 1.25 BCOP & 1.25 ACPE CE
  16. (BC6) Aiming for the Bullseye: Updates in Pediatric Solid Tumor Precision Medicine – 1.0 BCOP & 1.0 ACPE CE           
  17. (301) New Flavors: Bites in Hematologic Malignancies – 1.25 ACPE CE     
  18. (302) Breakout-Practical Issues for Clinicians: Ethical Dilemmas in Oncology Pharmacy: When Science and Morals Collide/The Gene Therapy Odyssey: Preparing the Pharmacist for New Horizons – 1.0 ACPE CE
  19. (303) Breakout- Updates in Hematology: Bispecifics in Lymphoma/Take a Bite out of Myeloma: The Role of Bi-Specific T-cell Engagers in the Treatment of Relapsed Refractory Multiple Myeloma – 1.0 ACPE CE
  20. (304) Breakout- Updates in Medical Oncology: Updates in the Management of Endometrial Cancer/ Expanding the Use of CDK4/6 Inhibitors to Early-Stage Breast Cancer Treatment – 1.0 ACPE CE
  21. (305) Buzzworthy Bladder Breakthroughs: Updates in Metastatic Bladder Cancer – 1.0 ACPE CE
  22. (306) Incorporating Sexual Orientation and Gender Identity Data into Oncology Patient Care – 1.25 ACPE CE
  23. (BC7) Up to My Neck (In Head and Neck Cancer Updates) – 1.0 BCOP & 1.0 ACPE CE
  24. (401) Clinical Pearls – 1.0 ACPE CE
  25. (402) To Treat or Not To Treat? The Role of Immunotherapy (IO) in Non Small Cell Lung Cancer (NSCLC) With Driver Alterations – 1.0 ACPE CE
  26. (403) Research Grant Award – 1.0 ACPE CE  
  27. (404) Updates in Chronic Lymphocytic Leukemia: Sequencing vs. Combination of Targeted Therapies – 1.0 ACPE CE
  28. (405) Igniting Breakthroughs in Pharmacogenetics & Genomics: Unveiling the Pathogenic Potential of VUS Through DEI Enhancement – 1.0 ACPE CE
  29. (406) Collaborative Practice in Clinical Trials: Reinforcements for the Crisis in Clinical Research – 1.0 ACPE CE
Get It!